Tuberculosis and human immunodeficiency virus infection

Medical Clinics of North America

Volumn 81, Issue 2, 1997, Pages 345-360

  Telzak, E E ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOSALICYLIC ACID; ANTIRETROVIRUS AGENT; CAPREOMYCIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

BACTERIUM CULTURE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG SENSITIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SPUTUM SMEAR; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0030933270     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70521-6     Document Type: Article

References (109)

1. D. Alland G.E. Kalkut A.R. Moss Transmission of tuberculosis in New York City: An analysis by DNA fingerprinting and conventional epidemiologic methods N Engl J Med 330 1994 1710
2. American Thoracic Society Treatment of tuberculosis and tuberculosis infection in adults and children Am J Respir Crit Care Med 149 1994 1359
3. Anastos K, Telzak E, Chirgwin K, et al: Prevalence and risk factors for tuberculin positivity in a cohort of HIV-infected and uninfected women at risk [Abstr Mo.B. 1370]. In Abstracts from the XI International Conference on AIDS, Vancouver, 1996
4. P. Barnes S. Barrows Tuberculosis in the 1990s Ann Intern Med 119 1993 400
5. C. Beck-Sague S.W. Dooley M.D. Hutton Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections: Factors in transmission to staff and HIV-infected patients JAMA 268 1992 1280
6. J. Berenguer S. Moreno F. Laguna Tuberculous meningitis in patients infected with the human immunodeficiency virus N Engl J Med 326 1992 668
7. S.E. Berning G.A. Huitt M.D. Iseman Malabsorption of antituberculous medications by a patient with AIDS [letter] N Engl J Med 327 1992 1817
8. B.R. Bloom C.J.L. Murray Tuberculosis: Commentary on a reemergent killer Science 257 1992 1055
9. T. Bodmer A. Gurtner K. Schopfer Screening of respiratory tract specimens for the presence of Mycobacterium tuberculosis by using the Gen-Probe amplified Mycobacterium tuberculosis tuberculosis direct test J Clin Microbiol 32 1994 1483
10. A. Brisson-Noel C. Aznar C. Chureau Diagnosis of tuberculosis by DNA amplification in clinical practice evaluation Lancet 338 1991 364
11. K. Brudney J. Dobkin Resurgent tuberculosis in New York City: Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs Am Rev Respir Dis 144 1991 745
12. D.R. Burwen A.B. Bloch L.D. Griffin National trends in the concurrence of tuberculosis and acquired immunodeficiency syndrome Arch Intern Med 155 1995 1281
13. G.M. Cauthen S.W. Dooley I.M. Onorato Transmission of Mycobacterium tuberculosis from tuberculosis patients with HIV infection or AIDS Am J Epidemiol 144 1996 69
14. Centers for Disease Control and Prevention Outbreak of multidrug-resistant tuberculosis—North Carolina MMWR 35 1987 785
15. Centers for Disease Control and Prevention A strategic plan for the elimination of tuberculosis in the United States MMWR 38 1989 1
16. Centers for Disease Control and Prevention Outbreak of multidrug-resistant tuberculosis—Texas, California, and Pennsylvania MMWR 39 1990 369
17. Centers for Disease Control and Prevention Purified protein derivative (PPD)—tuberculin anergy and HIV infection: Guidelines for anergy testing and management of anergic persons at risk of tuberculosis MMWR 40 1991 27
18. Centers for Disease Control and Prevention Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons—Florida and New York MMWR 40 1991 585
19. Centers for Disease Control and Prevention Transmission of multidrug-resistant tuberculosis from an HIV-positive client in a residential substance-abuse treatment facility—Michigan MMWR 40 1991 129
20. Centers for Disease Control and Prevention National action plan to combat multidrug-resistant tuberculosis MMWR 41 1992 1
21. Centers for Disease Control and Prevention Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system—New York MMWR 41 1992 507
22. Centers for Disease Control and Prevention Management of persons exposed to multidrug-resistant tuberculosis MMWR 41 1992 61
23. Centers for Disease Control and Prevention Tuberculosis morbidity—United States, 1995 MMWR 45 1996 365
24. Centers for Disease Control and Prevention Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994 MMWR 43 1994 1 120
25. R.E. Chaisson G. Slutkin Tuberculosis and human immunodeficiency virus infection J Infect Dis 159 1989 96
26. J.E. Clarridge III R.M. Shawar T.M. Shinnick Large-scale use of polymerase chain reaction for detection of Mycobacterium tuberculosis in a routine mycobacteriology laboratory J Clin Microbiol 31 1993 2049
27. D.L. Cohn B.J. Catlin K.L. Peterson A 62 dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis: A twice-weekly, directly-observed and cost-effective regimen Ann Intern Med 112 1990 407
28. D.L. Combs R.J. O'Brien L.J. Geiter USPHS tuberculosis short-course chemotherapy trial 21: Effectiveness, toxicity, and acceptability: The report of final results Ann Intern Med 112 1990 397
29. D.V. Cousins S.D. Wilton B.R. Francis Use of polymerase chain reaction for rapid diagnosis of tuberculosis J Clin Microbiol 30 1992 255
30. C.L. Daley P.M. Small G.F. Schecter An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: An analysis using restriction-fragment length polymorphisms N Engl J Med 326 1992 231
31. K.M. De Cock A. Grant J.D.H. Porter Preventive therapy for tuberculosis in HIV-infected persons: International recommendations, research and practice Lancet 345 1995 833
32. G. Di Perri M. Cruciani M.C. Danzi Nosocomial epidemic of active tuberculosis among HIV-infected patients Lancet 2 1989 1502
33. S.W. Dooley M.E. Villarino M. Lawrence Nosocomial transmission of tuberculosis in a hospital unit for HIV-infected patients JAMA 267 1992 2632
34. J. Dylewski L. Thibert Failure of tuberculous chemotherapy in a human immunodeficiency virus-infected patient [letter] J Infect Dis 162 1990 778
35. B.R. Edlin J.I. Tokars M.H. Grieco An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome N Engl J Med 326 1992 1514
36. A.M. Elliot R.J. Hayes B. Halwiindi The impact of HIV on infectiousness of pulmonary tuberculosis: A community study in Zambia AIDS 7 1993 981
37. B.A. Fazal E.E. Telzak S. Blum Impact of a coordinated tuberculosis team in an inner-city hospital in New York City Infect Control Hosp Epidemiol 16 1995 340
38. M.A. Fischl G.L. Daikos R.B. Uttamchandani Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug resistant bacilli Ann Intern Med 117 1992 184
39. M.A. Fischl R.B. Uttamchandani G.L. Daikos An outbreak of tuberculosis caused by multiple drug-resistant tubercle bacilli among patients with HIV infection Ann Intern Med 117 1992 177
40. T.R. Frieden P.I. Fujiwara R.M. Washko Tuberculosis in New York City—turning the tide N Engl J Med 333 1995 229
41. T.R. Frieden T. Sterling A. Pablos-Mendez The emergence of drug-resistant tuberculosis in New York City N Engl J Med 328 1993 521
42. P.I. Fujiwara T.R. Frieden Tuberculosis control and epidemiology in the inner city W.N. Rom S. Garay Tuberculosis 1996 Little, Brown Boston 99
43. M. Goble M.D. Iseman L.A. Madsen Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin N Engl J Med 328 1993 527
44. N.M.H. Graham K.E. Nelson L. Solomon Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users JAMA 267 1992 369
45. J.H. Grosset Present status of chemotherapy for tuberculosis Rev Infect Dis 11 1989 S347
46. C.R. Haley L. McDonald W. Rossi Tuberculosis epidemic among hospital personnel Infect Control Hosp Epidemiol 10 1989 204
47. B.A. Hanna Diagnosis of tuberculosis by microbiologic techniques W.N. Rom S. Garay Tuberculosis 1966 Little, Brown Boston 149
48. M. Hawken P. Nunn S. Gathua Increased recurrence of tuberculosis in HIV-1 infected patients in Kenya Lancet 342 1993 332
49. D. Horn D. Hewlett C. Alfalla Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis [letter] N Engl J Med 330 1994 1241
50. M.D. Iseman A leap of faith: What can we do to curtail intrainstitutional transmission of tuberculosis? Ann Intern Med 117 1992 251
51. M.D. Iseman Treatment of multidrug-resistant tuberculosis N Engl J Med 329 1993 784
52. M.D. Iseman D.L. Cohn J.A. Sbarbaro Directly observed treatment of tuberculosis—we can't afford not to try it [edit] N Engl J Med 328 1993 576
53. W.R. Jacobs R.G. Barletta T. Udani Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages Science 260 1993 819
54. T.E. Kiehn The diagnostic mycobacteriology laboratory of the 1990s Clin Infect Dis 17 suppl 2 1993 S447
55. J.D. Klausner R.W. Ryder E. Baende Mycobacterium tuberculosis in household contacts of human immunodeficiency virus type 1–seropositive patients with active pulmonary tuberculosis in Kinshasa, Zaire J Infect Dis 168 1993 106
56. N.C. Klein F.P. Duncanson T.H. Lenox III Use of mycobacterial smears in the diagnosis of pulmonary tuberculosis in AIDS/ARC patients Chest 95 1989 1190
57. M.M. Lederman D.L. Georges D.J. Kusner Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus J Acquir Immune Defic Syndr 7 1994 727
58. R. Long M. Scalcini J. Manfreda The impact of HIV on the usefulness of sputum smears for the diagnosis of tuberculosis Am J Public Health 81 1991 1326
59. S.A. Maloney M.L. Pearson M.T. Gordon Efficacy of control measures in preventing nosocomial transmission of multidrug-resistant tuberculosis to patients and health care workers Ann Intern Med 122 1995 90
60. D. Mitchison Pyrazinamide in the chemoprophylaxis of tuberculosis [letter] Am Rev Respir Dis 142 1990 1467
61. S. Moreno J. Baraia-Etxaburu E. Bouza Risk for developing tuberculosis among anergic patients infected with HIV Ann Intern Med 119 1993 194
62. New York City Department of Health, Bureau of Tuberculosis Control Information summary, 1995 1995 New York City Department of Health
63. G.T. Noordhoek A.H.J. Kolk G. Bjune Sensitivity and specificity of PCR for detection of Mycobacterium tuberculosis : A blind comparison study among seven laboratories J Clin Microbiol 32 1994 277
64. I.M. Onorato E. McCray the Field Services Branch Prevalence of human immunodeficiency virus infection among patients attending tuberculosis clinics in the United States J Infect Dis 165 1992 87
65. J.K. Onwubalili A.J. Edwards L. Palmer T4 lymphopenia in human tuberculosis Tubercle 68 1987 195
66. J.W. Pape S.S. Simone J.L. Ho Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection Lancet 342 1993 268
67. M.M. Park A.L. Davis N.W. Schluger Outcome of MDR-TB patients, 1983–1993: Prolonged survival with appropriate therapy Am J Respir Crit Care Med 153 1996 317
68. M.L. Pearson J.A. Jareb T.R. Frieden Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis Ann Intern Med 117 1992 191
69. C.F. Pegues D.C. Johnson D.A. Pegues Implementation and evaluation of an algorithm for isolation of patients with suspected pulmonary tuberculosis Infect Control Hosp Epidemiol 17 1996 412
70. C.A. Peloquin A.A. MacPhee S.E. Berning Malabsorption of antimycobacterial medications N Engl J Med 329 1993 1122
71. Perlman DC, El-Sadr W, Nelson E, et al: Radiographic presentation of HIV-related tuberculosis vary by CD4 count [abstr]. In Abstracts of the Annual Meeting of the Infectious Diseases Society of America, San Francisco, 1995
72. J.H. Perriens M.E. St. Louis Y.B. Mukadi Pulmonary tuberculosis in HIV-infected patients in Zaire: A controlled trial of treatment for either 6 or 12 months N Engl J Med 332 1995 779
73. J.R. Pierce S.L. Sims G.H. Holman Transmission of tuberculosis to hospital workers by a patient with AIDS Chest 101 1992 581
74. A. Pitchenik H. Rubinson The radiographic appearance of tuberculosis in patients with the acquired immune deficiency syndrome (AIDS) and pre-AIDS Am Rev Respir Dis 135 1985 875
75. A.L. Pozniak J. Weinberg M. Mahari Tuberculous pericardial effusion associated with HIV infection: A sign of disseminated disease Tubercle Lung Dis 75 1994 297
76. M.C. Raviglione J.P. Narain A. Kochi HIV-associated tuberculosis in developing countries: Clinical features, diagnosis, and treatment WHO Bull OMS 70 1992 515
77. H.L. Rieder G.M. Cauthen A.B. Bloch Tuberculosis and acquired immunodeficiency syndrome—Florida Arch Intern Med 149 1989 1268
78. G.D. Roberts N.L. Goodman L. Heifets Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens J Clin Microbiol 18 1983 689
79. N. Salomon D.C. Perlman P. Friedman Predictors and outcome of multidrug-resistant tuberculosis Clin Infect Dis 21 1995 1245
80. B.R. Saltzman M.R. Motyl G.H. Friedland Mycobacterium tuberculosis bacteremia in the acquired immunodeficiency syndrome JAMA 256 1986 390
81. N.W. Schluger The polymerase chain reaction in the diagnosis of tuberculosis W.N. Rom S. Garay Tuberculosis 1996 Little, Brown Boston 233
82. N.W. Schluger R. Condos S. Lewis Amplification of DNA of Mycobacterium tuberculosis from peripheral blood of patients with pulmonary tuberculosis Lancet 344 1994 232
83. P.A. Selwyn D. Hartel V.A. Lewis A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection N Engl J Med 320 1989 545
84. P.A. Selwyn B.M. Sckell P. Alcabes High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy JAMA 268 1992 504
85. K.A. Sepkowitz Tuberculosis and the health care worker: A historical perspective Ann Intern Med 120 1994 71
86. K.A. Sepkowitz J. Raffalli L. Riley Tuberculosis in the AIDS era Clin Microbiol Rev 8 1995 180
87. K.A. Sepkowitz E.E. Telzak S. Recalde Tuberculosis susceptibility trends in New York City, 1987–1991 Clin Infect Dis 18 1994 755
88. R.W. Shafer K.D. Chirgwin A.E. Glatt HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS AIDS 5 1991 399
89. R.W. Shafer B.R. Edlin Tuberculosis in patients infected with human immunodeficiency virus: Perspectives on the past decade Clin Infect Dis 22 1996 683
90. R.W. Shafer D.S. Kim J.P. Weiss Extrapulmonary tuberculosis in patients with human immunodeficiency virus infection Medicine 70 1991 384
91. T.M. Shinnick R.C. Good Diagnostic mycobacteriology laboratory practices Clin Infect Dis 21 1995 291
92. K.A. Shriner G.E. Mathisen M.B. Goetz Comparison of mycobacterial lymphadenitis among persons infected with human immunodeficiency virus and seronegative controls Clin Infect Dis 15 1992 601
93. P. Small G. Schecter P. Goodman Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection N Engl J Med 324 1991 289
94. P.C. Small P.C. Hopewell S.P. Singh The epidemiology of tuberculosis in San Francisco: A population-based study using conventional and molecular methods N Engl J Med 330 1994 1703
95. P.M. Small R.W. Shafer P.C. Hopewell Exogenous reinfection with multidrug- resistant Mycobacterium tuberculosis in patients with advanced HIV infection N Engl J Med 328 1993 1137
96. R.J. Stack L.K. Bickley I.G. Coppel Miliary tuberculosis presenting as skin lesions in a patient with acquired immunodeficiency syndrome J Am Acad Dermatol 23 1990 1031
97. W.W. Stead Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: Recrudescence of residuals of the primary infection or exogenous reinfection? Am Rev Respir Dis 95 1967 729
98. R. Stoneburner E. Laroche R. Prevots Survival in a cohort of human immunodeficiency virus-infected tuberculosis patients in New York City Arch Intern Med 152 1992 2033
99. Telzak EE, Fazal BA, Pollard CL, et al: Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis [Abstr 126]. In Proceedings of the Lancet Conference/The Challenge of Tuberculosis, Washington, DC, 1995
100. E.E. Telzak K. Sepkowitz P. Alpert Multidrug-resistant tuberculosis in patients without HIV infection N Engl J Med 33 1995 907
101. R. Torres S. Mani J. Altholz Human immunodeficiency virus infection among homeless men in a New York City shelter—association with Mycobacterium tuberculosis infection Arch Intern Med 150 1990 2030
102. G.S. Turett E.E. Telzak Normalization of CD4+ T-lymphocyte depletion in persons without HIV infection treated for tuberculosis Chest 105 1994 1335
103. G.S. Turett E.E. Telzak L.V. Torian Improved outcomes of patients with multidrug-resistant tuberculosis Clin Infect Dis 21 1995 1238
104. Wadhawan D, Hira S, Mwansa N, et al: Preventive tuberculosis chemotherapy with isoniazid among patients infected with HIV-1 [abstr PO-BO7-1114]. In Abstracts of the IXth International Conference on AIDS, Berlin, 1993
105. R.S. Wallis M. Vjecha M. Amir-Tahmasseb Influence of tuberculosis on human immunodeficiency virus (HIV-1): Enhanced cytokine expression and elevated B2-microglobulin in HIV-1-associated tuberculosis J Infect Dis 167 1993 43
106. C.T. Webster F.M. Gordin J.P. Matts Two-stage tuberculin skin testing in individuals with human immunodeficiency virus infection Am J Respir Crit Care Med 151 1995 805
107. S.E. Weis P.C. Slocum F.X. Blais The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis N Engl J Med 330 1994 1179
108. P.N. Wenger J. Otten A. Breeden Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among health-care workers and HIV-infected patients Lancet 345 1995 235
109. C. Whalen C.R. Horsburgh D. Hom Accelerated course of human immunodeficiency virus infection after tuberculosis Am J Respir Crit Care Med 151 1995 129